Cadrenal Therapeutics (CVKD) Insider Trading & Ownership $16.17 +1.68 (+11.59%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Cadrenal Therapeutics (NASDAQ:CVKD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage48.62%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$123,131.70Number OfInsiders Selling(Last 3 Years)0 Get CVKD Insider Trade Alerts Want to know when executives and insiders are buying or selling Cadrenal Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CVKD Insider Buying and Selling by Quarter Ad Porter & CompanyI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Cadrenal Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/4/2023John Raymond MurphyDirectorBuy17,331$0.70$12,131.70 9/1/2023Quang X PhamCEOBuy70,000$0.91$63,700.00 3/21/2023John Raymond MurphyDirectorBuy10,000$1.39$13,900.00 3/16/2023John Raymond MurphyDirectorBuy20,000$1.67$33,400.00 (Data available from 1/1/2013 forward) CVKD Insider Trading Activity - Frequently Asked Questions Who is on Cadrenal Therapeutics's Insider Roster? The list of insiders at Cadrenal Therapeutics includes John Raymond Murphy, and Quang X Pham. Learn more on insiders at CVKD. What percentage of Cadrenal Therapeutics stock is owned by insiders? 48.62% of Cadrenal Therapeutics stock is owned by insiders. Learn more on CVKD's insider holdings. Which Cadrenal Therapeutics insiders have been buying company stock? The following insiders have purchased CVKD shares in the last 24 months: John Raymond Murphy ($59,431.70), and Quang X Pham ($63,700.00). How much insider buying is happening at Cadrenal Therapeutics? Insiders have purchased a total of 117,331 CVKD shares in the last 24 months for a total of $123,131.70 bought. Cadrenal Therapeutics Key ExecutivesMr. Quang X. Pham (Age 59)Chairman & CEO Compensation: $967kMr. Matthew K. Szot CPA (Age 50)CPA, Chief Financial Officer Compensation: $594.89kDr. Douglas W. Losordo FACC (Age 66)FAHA, M.D., Chief Medical Officer Compensation: $528.69kMr. Jeffrey ColeChief Operating Officer More Insider Trading Tools from MarketBeat Related Companies UNCY Insider Trading EPIX Insider Trading ZIVO Insider Trading VOR Insider Trading VTGN Insider Trading OPTN Insider Trading RPTX Insider Trading BCAB Insider Trading DBVT Insider Trading CUE Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:CVKD) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cadrenal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cadrenal Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
